| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/13/2006 | WO2006039221A2 Cyclopropyl piperidine glycine transporter inhibitors |
| 04/13/2006 | WO2006039215A2 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 04/13/2006 | WO2006039212A2 Substituted 2h-1,3-benzoxazin-4(3h)-ones |
| 04/13/2006 | WO2006039113A2 1-chloro-2,4-dinitrobenzene gel compositions and methods for using the same |
| 04/13/2006 | WO2006038989A1 Substituted arylamides |
| 04/13/2006 | WO2006038931A2 Odor-reducing quinone compounds |
| 04/13/2006 | WO2006038923A2 Aryl substituted imidazonaphthyridines |
| 04/13/2006 | WO2006038871A1 New hydroxymethylbenzothiazoles amides |
| 04/13/2006 | WO2006038865A1 Nucleotide derivatives for the treatment of type 2 diabetes and other disorders |
| 04/13/2006 | WO2006038797A1 Use of statin or precursor thereof for the treatment of hiv infections |
| 04/13/2006 | WO2006038738A1 Receptor function regulating agent |
| 04/13/2006 | WO2006038734A1 Pyridazinone derivatives cytokines inhibitors |
| 04/13/2006 | WO2006038729A1 Mutated amyloid protein |
| 04/13/2006 | WO2006038719A1 Phosphonic acid derivative and therapeutic agent for disease in which high phosphate level in blood participates |
| 04/13/2006 | WO2006038680A1 2-arylcarboxamide-nitrogeneous heterocycle compound |
| 04/13/2006 | WO2006038661A1 Medicinal composition, process for producing the same, and method of stabilizing dihydropyridine compound in medicinal composition |
| 04/13/2006 | WO2006038656A1 Allergy suppressant |
| 04/13/2006 | WO2006038619A1 Medicinal composition for prevention of transition to operative treatment for prostatic hypertrophy |
| 04/13/2006 | WO2006038613A1 Oral composition containing difructose anhydride |
| 04/13/2006 | WO2006038611A1 Preventive and/or therapeutic agent for urine collection disorder accompanying lower urinary tract obstruction |
| 04/13/2006 | WO2006038608A1 Oligo double-stranded rna and medicinal composition |
| 04/13/2006 | WO2006038606A1 Biaryl derivative |
| 04/13/2006 | WO2006038603A1 Phosphate ion adsorbent |
| 04/13/2006 | WO2006038596A1 Pharmaceutical composition for xerophthalmia and xerostomia treatment |
| 04/13/2006 | WO2006038594A1 N-type calcium channel inhibitor |
| 04/13/2006 | WO2006038550A1 Medicinal composition for prevention or treatment of parasitic protozoan infection |
| 04/13/2006 | WO2006038526A1 Acid addition salt of irinotecan |
| 04/13/2006 | WO2006038513A1 Anti-trypanosomiasis agent |
| 04/13/2006 | WO2006038462A1 Novel steroid-producing cell |
| 04/13/2006 | WO2006038226A2 Process for making a highly compressible controlled delivery compositions of metformin |
| 04/13/2006 | WO2006038172A1 New piperidine antibiotics |
| 04/13/2006 | WO2006038116A2 Triazolopyridine derivatives as antibacterial agents |
| 04/13/2006 | WO2006038112A1 Use of kinase inhibitors to promote neochondrogenesis |
| 04/13/2006 | WO2006038111A1 Benzoimidazole derivatives useful as antiproliferative agents |
| 04/13/2006 | WO2006038100A1 Oxazolidinone derivatives as antimicrobials |
| 04/13/2006 | WO2006038084A1 Use of pharmaceutical compositions of lofepramine for the treatment of adhd, cfs, fm and depression |
| 04/13/2006 | WO2006038041A1 Besylate salts of six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain |
| 04/13/2006 | WO2006038039A1 Modulators of hcv replication |
| 04/13/2006 | WO2006038006A2 5-sulfonyl-1-piperidinyl substituted indole derivatives as 5-ht6 receptor antagonists for the treatment of cns disorders |
| 04/13/2006 | WO2006037996A1 Novel cyclic and acyclic propenones for treating cns disorders |
| 04/13/2006 | WO2006037981A1 Inhibition of tumour cell migration |
| 04/13/2006 | WO2006037958A2 Treatment of helminth infection by inhibition of tyrosinase |
| 04/13/2006 | WO2006037875A1 Novel bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors |
| 04/13/2006 | WO2006037869A2 Fluorophosphonocinnamic compounds, synthesis and uses for treating disorders caused by oxidative stress |
| 04/13/2006 | WO2006037848A1 Method and preparation for binding aldehydes in saliva |
| 04/13/2006 | WO2006037827A1 Solid pharmaceutical composition comprising the thiazolyl methyl ester of [5s-(5r*,8r*,10r*,11r*)]-10-hydroxy-2-methyl-5-(1-methylethyl)-1-[2-1(1-methylethyl)-4-thiazolyl]-3,6-dioxo-8,11-bis(phenylmethyl)-2,4,7,12-tetraazatridecan-13-oic acid and preparation method thereof |
| 04/13/2006 | WO2006037771A1 Pulmonary administration of an antithrombotic compound |
| 04/13/2006 | WO2006037769A1 Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases. |
| 04/13/2006 | WO2006037766A1 Oral pharmaceutical preparation comprising a proton pump antagonist and a basic excipient |
| 04/13/2006 | WO2006037763A1 Oral pharmaceutical preparation for proton pump antagonists |
| 04/13/2006 | WO2006037761A1 New histone deacetylases inhibitors |
| 04/13/2006 | WO2006037748A1 Substituted tricyclic benzimidazoles |
| 04/13/2006 | WO2006037650A1 Lercanidipine capsules |
| 04/13/2006 | WO2006037592A1 Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions |
| 04/13/2006 | WO2006037496A1 Polyhalogenated propene benzoquinone dioxime derivatives and its use as pesticides |
| 04/13/2006 | WO2006037491A1 A guanylane cyclase stimulator and nitric oxide for treating bronchoconstriction and pulmonary vasoconstriction |
| 04/13/2006 | WO2006037482A2 Compositions and methods for treating cognitive disorders |
| 04/13/2006 | WO2006037481A1 Benzoxazine and quinoxaline derivatives and uses |
| 04/13/2006 | WO2006037480A1 Hexafluoroisopropanol substituted ether derivatives |
| 04/13/2006 | WO2006037468A1 Hiv reverse transcriptase inhibitors |
| 04/13/2006 | WO2006037452A1 NOVEL USE OF α-SYMPATHOMIMETICS HAVING A 2-IMIDAZOLINE STRUCTURE |
| 04/13/2006 | WO2006037449A2 Iron complex for use in the treatment and/or prevention of nutritional disorders |
| 04/13/2006 | WO2006037348A1 Pharmaceutical compositions comprising fenofibrate and a statin |
| 04/13/2006 | WO2006037347A1 Pharmaceutical compositions comprising fenofibrate and atorvastatin |
| 04/13/2006 | WO2006037346A1 Pharmaceutical compositions comprising fenofibrate and simvastatin |
| 04/13/2006 | WO2006037345A1 Pharmaceutical composition comprising fenofibrate and simvastatin |
| 04/13/2006 | WO2006037344A1 Pharmaceutical compositions comprising fenofibrate and atorvastatin |
| 04/13/2006 | WO2006037335A2 Use of compounds for the prevention of drug-induced cell toxicity |
| 04/13/2006 | WO2006037185A1 Novel sulfenamides and sulfenamide oxides |
| 04/13/2006 | WO2006031556A3 Amidine substituted aryl aniline compounds |
| 04/13/2006 | WO2006031284A3 Covered stent with controlled therapeutic agent diffusion |
| 04/13/2006 | WO2006024770A3 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 04/13/2006 | WO2006023342A3 Synergistic conjugated linoleic acid (cla) and carnitine combination |
| 04/13/2006 | WO2006021401A3 Bicylononene derivatives |
| 04/13/2006 | WO2006021001A3 Amphiphilic polynorbornene derivatives and methods of using the same |
| 04/13/2006 | WO2006020070A3 Indanylamino uracils and their use as antioxidants and neuroprotectants |
| 04/13/2006 | WO2006019327A3 Deuterium depleted water (ddw) using as adjuvant in cancer therapy for cytostatics toxicity reduction |
| 04/13/2006 | WO2006018521A3 Compounds and methods for controlling alcohol intake |
| 04/13/2006 | WO2006018185A3 Dihydropteridinones for the treatment of cancer diseases |
| 04/13/2006 | WO2006017347A3 Opthalmic compositions and methods for treating ophthalmic conditions |
| 04/13/2006 | WO2006016167A3 17-desmethylrapamycin and analogues thereof, methods for their roduction and their use as immunosupressants, anticancer agents, antifungal agents, etc. |
| 04/13/2006 | WO2006014973A3 Pharmaceutical dosage forms including rasagiline |
| 04/13/2006 | WO2006012373A3 Combination therapies of hmgb and complement inhibitors against inflammation |
| 04/13/2006 | WO2006010546A3 Aryl-pyridine derivatives as 11-beta-hsd1 inhibitors |
| 04/13/2006 | WO2006007540A3 Piperidine derivatives as nk1 antagonists |
| 04/13/2006 | WO2006005602A3 Use of ecteinascidin in the treatment of cancer in patients with low level of brca1 |
| 04/13/2006 | WO2006004931A3 Substituted azepine derivatives as serotonin receptor modulators |
| 04/13/2006 | WO2006004841A3 Galanin agonists |
| 04/13/2006 | WO2006003500A8 Method for preparing 5-`4-(2-hydroxy-propyl)-3,5-dioxo-4,5-dihydro-3h`1,2,4!triazin-2-yl!-benzamide derivatives by deprotecting the hydroxyl-protected precursers |
| 04/13/2006 | WO2006000421A3 Ige antibody repressing agent comprising alpha cyclodextrin |
| 04/13/2006 | WO2005123694A3 Quinazolinone compounds for the treatment of cough |
| 04/13/2006 | WO2005123651A8 L-2-(α-HYDROXYPENTYL)BENZOATES, THE PREPARATION AND THE USE THEREOF |
| 04/13/2006 | WO2005122791A3 Improvement of barrier integrity in hiv patients with fatty acids |
| 04/13/2006 | WO2005120642A3 Tetrahydropyridothiophenes for treating hyperproliferative disorders |
| 04/13/2006 | WO2005117897A3 Hepoxilins and modulators of ichthyin for treatment skin disorders |
| 04/13/2006 | WO2005116032A3 Reverse-turn mimetics and method relating thereto |
| 04/13/2006 | WO2005116027A3 Indazole and indolone derivatives and their use as pharmaceuticals |
| 04/13/2006 | WO2005114180A3 Functional ghs-r antagonists |
| 04/13/2006 | WO2005112953A3 Treatment of hypercholesterolemia, hypertriglyceridemia and cardiovascular-related conditions using phosphalipase-a2 inhibitors |
| 04/13/2006 | WO2005112947A3 Use of atp for the manufacture of a medicament for the prevention and treatment of oxidative stress and related conditions |